Federation Des Caisses Desjardins Du Quebec Abbott Laboratories Transaction History

Federation Des Caisses Desjardins Du Quebec

$23.7 Billion
Q3 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Abbott Laboratories stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 233,187 shares of ABT stock, worth $30.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

233,187

Previous 177,824 31.13%

Holding current value

$30.3 Million

Previous $24.2 Million 29.14%

% of portfolio

0.13%

Previous 0.11%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$120.51 - $136.62 $6.67 Million - $7.56 Million	55,363 Added 31.13%	233,187 $31.2 Million
Q2 2025 Aug 14, 2025	SELL	$123.95 - $138.08 $2.85 Million - $3.17 Million	-22,964 Reduced 11.44%	177,824 $24.2 Million
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $3.14 Million - $3.97 Million	-28,294 Reduced 12.35%	200,788 $26.6 Million
Q4 2024 Feb 13, 2025	SELL	$111.93 - $119.39 $94,356 - $100,645	-843 Reduced 0.37%	229,082 $25.9 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $12.3 Million - $14.5 Million	-122,902 Reduced 34.83%	229,925 $26.2 Million

Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $4.56 Million - $5.09 Million	-45,230 Reduced 11.36%	352,827 $36.7 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $43.6 Million - $48.1 Million	398,057 New	398,057 $44.8 Billion
Q4 2023 Aug 14, 2024	SELL	$90.19 - $110.4 $2.25 Million - $2.76 Million	-24,996 Reduced 7.73%	298,259 $32.8 Billion
Q3 2023 Aug 14, 2024	SELL	$95.53 - $114.62 $426,828 - $512,122	-4,468 Reduced 1.36%	323,255 $31.3 Billion
Q2 2023 Aug 14, 2024	BUY	$100.78 - $112.29 $2.89 Million - $3.22 Million	28,659 Added 9.58%	327,723 $35.7 Billion
Q1 2023 Aug 14, 2024	BUY	$96.86 - $114.01 $18.5 Million - $21.8 Million	191,004 Added 176.76%	299,064 $30.3 Billion
Q4 2022 Aug 14, 2024	SELL	$95.06 - $111.52 $15.8 Million - $18.5 Million	-166,274 Reduced 60.61%	108,060 $11.9 Billion
Q3 2022 Aug 14, 2024	BUY	$96.76 - $112.03 $2.59 Million - $3 Million	26,797 Added 10.83%	274,334 $26.5 Billion
Q2 2022 Aug 14, 2024	BUY	$102.07 - $123.37 $883,007 - $1.07 Million	8,651 Added 3.62%	247,537 $26.9 Billion
Q1 2022 Aug 14, 2024	SELL	$114.02 - $139.04 $13 Million - $15.8 Million	-113,941 Reduced 32.29%	238,886 $28.3 Billion
Q4 2021 Aug 30, 2024	BUY	$115.53 - $141.46 $5.76 Million - $7.05 Million	49,820 Added 26.53%	237,573 $33.4 Billion
Q3 2021 Aug 30, 2024	BUY	$116.66 - $129.06 $924,880 - $1.02 Million	7,928 Added 4.41%	187,753 $22.2 Billion
Q2 2021 Aug 30, 2024	SELL	$105.79 - $124.53 $18.3 Million - $21.5 Million	-173,002 Reduced 49.03%	179,825 $20.8 Billion
Q1 2021 Aug 30, 2024	BUY	$108.84 - $128.23 $9.31 Million - $11 Million	85,506 Added 107.97%	164,700 $19.7 Billion
Q4 2020 Aug 30, 2024	BUY	$105.0 - $114.42 $2.93 Million - $3.19 Million	27,894 Added 54.37%	79,194 $8.67 Billion
Q3 2020 Aug 30, 2024	BUY	$91.64 - $111.29 $46,278 - $56,201	505 Added 0.99%	51,300 $5.58 Billion
Q2 2020 Aug 30, 2024	SELL	$76.57 - $98.0 $90,735 - $116,130	-1,185 Reduced 2.28%	50,795 $4.64 Billion
Q1 2020 Aug 30, 2024	SELL	$62.82 - $91.86 $313,723 - $458,748	-4,994 Reduced 8.77%	51,980 $4.1 Billion
Q4 2019 Aug 30, 2024	SELL	$78.51 - $87.4 $124,752 - $138,878	-1,589 Reduced 2.71%	56,974 $4.95 Billion
Q3 2019 Aug 30, 2024	SELL	$81.84 - $88.74 $890,910 - $966,023	-10,886 Reduced 15.67%	58,563 $4.9 Billion
Q2 2019 Aug 30, 2024	SELL	$72.88 - $85.0 $373,145 - $435,200	-5,120 Reduced 6.87%	69,449 $5.84 Billion
Q1 2019 Aug 30, 2024	BUY	$66.22 - $80.06 $101,449 - $122,651	1,532 Added 2.1%	74,569 $5.96 Billion
Q4 2018 Aug 30, 2024	SELL	$65.56 - $74.27 $18.3 Million - $20.8 Million	-279,790 Reduced 79.3%	73,037 $5.28 Billion
Q3 2018 Aug 30, 2024	SELL	$60.81 - $73.36 $142,173 - $171,515	-2,338 Reduced 3.15%	71,834 $5.27 Billion
Q2 2018 Aug 30, 2024	SELL	$57.57 - $63.54 $109,325 - $120,662	-1,899 Reduced 2.5%	74,172 $4.52 Billion
Q1 2018 Aug 30, 2024	SELL	$56.27 - $63.62 $349,886 - $395,589	-6,218 Reduced 7.56%	76,071 $4.56 Billion
Q4 2017 Aug 30, 2024	SELL	$53.68 - $57.47 $137,850 - $147,582	-2,568 Reduced 3.03%	82,289 $4.7 Billion
Q3 2017 Aug 30, 2024	BUY	$48.06 - $53.64 $14,369 - $16,038	299 Added 0.35%	84,857 $4.53 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	10,634 Added 14.39%	84,558 $4.11 Billion
Q1 2017 Aug 30, 2024	SELL	N/A	-278,903	73,924 $3.28 Billion

Others Institutions Holding ABT

# of Institutions

3,643

Shares Held

1.39B

Call Options Held

10.2M

Put Options Held

8.93M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Abbott Laboratories Transaction History